Ligand Pharmaceuticals Incorporated(NASDAQ:LGND) 
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. The company's commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; ...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 99.17
H 101.15
L 96.95
C 99.57
V 165,795
10EMA 99.57
20EMA 99.57
60EMA 99.57
120EMA 99.57
250EMA 99.57